April 2024
1. PAPINI C, Ullah I, Ranjan AP, Zhang S, et al
   Proof-of-concept studies with a computationally designed M(pro) inhibitor as a synergistic combination regimen alternative to Paxlovid.
   Proc Natl Acad Sci U S A. 2024;121:e2320713121.
   

   >> Share

   
   
2. SACCHI P, Wright SE, Neoptolemou P, Lampronti GI, et al
   Crystal size, shape, and conformational changes drive both the disappearance and reappearance of ritonavir polymorphs in the mill.
   Proc Natl Acad Sci U S A. 2024;121:e2319127121.
   

   >> Share

   
   December 2023
3. ENGFER ZJ, Lewandowski D, Dong Z, Palczewska G, et al
   Distinct mouse models of Stargardt disease display differences in pharmacological targeting of ceramides and inflammatory responses.
   Proc Natl Acad Sci U S A. 2023;120:e2314698120.
   

   >> Share

   
   May 2023
4. DASH PK, Chen C, Kaminski R, Su H, et al
   CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice.
   Proc Natl Acad Sci U S A. 2023;120:e2217887120.
   

   >> Share

   
   March 2023
5. KIM Y, Ryu JY, Kim HU, Lee SY, et al
   Computational prediction of interactions between Paxlovid and prescription drugs.
   Proc Natl Acad Sci U S A. 2023;120:e2221857120.
   

   >> Share

   
   December 2022
6. NOVOTOTSKAYA-VLASOVA KA, Neznanov NS, Molodtsov I, Hall BM, et al
   Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors.
   Proc Natl Acad Sci U S A. 2022;119:e2213146119.
   

   >> Share

   
   July 2022
7. SINGH AK, De Wijngaert B, Bijnens M, Uyttersprot K, et al
   Cryo-EM structures of wild-type and E138K/M184I mutant HIV-1 RT/DNA complexed with inhibitors doravirine and rilpivirine.
   Proc Natl Acad Sci U S A. 2022;119:e2203660119.
   

   >> Share

   
   April 2021
8. LOPEZ ANGEL CJ, Pham EA, Du H, Vallania F, et al
   Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination.
   Proc Natl Acad Sci U S A. 2021;118.
   

   >> Share

   
   February 2021
9. MA C, Wang J
   Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors.
   Proc Natl Acad Sci U S A. 2021;118.
   

   >> Share

   
   
10. LI Z, Lin Y, Huang YY, Liu R, et al
    Reply to Ma and Wang: Reliability of various in vitro activity assays on SARS-CoV-2 main protease inhibitors.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    
11. JAN JT, Cheng TR, Juang YP, Ma HH, et al
    Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    January 2021
12. MONTEFIORI DC, Filsinger Interrante MV, Bell BN, Rubio AA, et al
    The high-affinity immunoglobulin receptor FcgammaRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    May 2020
13. DROSU NC, Edelman ER, Housman DE
    Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic DNA replication by targeting the viral DNA polymerase.
    Proc Natl Acad Sci U S A. 2020 May 14. pii: 2002392117.
    

    >> Share

    
    April 2020
14. GUPTA S, Louis JM, Tycko R
    Effects of an HIV-1 maturation inhibitor on the structure and dynamics of CA-SP1 junction helices in virus-like particles.
    Proc Natl Acad Sci U S A. 2020 Apr 27. pii: 1917755117.
    

    >> Share

    
    
15. ANDRADE VM, Mavian C, Babic D, Cordeiro T, et al
    A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption.
    Proc Natl Acad Sci U S A. 2020 Apr 16. pii: 1917034117.
    

    >> Share

    
    November 2019
16. CRAKES KR, Santos Rocha C, Grishina I, Hirao LA, et al
    PPARalpha-targeted mitochondrial bioenergetics mediate repair of intestinal barriers at the host-microbe intersection during SIV infection.
    Proc Natl Acad Sci U S A. 2019 Nov 18. pii: 1908977116.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share